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SUMMARY.
1. The number and size of lung adenomas produced in RIII, CBA and C57
mice by urethane decreased in that order. This is the same order as the incidence
of spontaneous lung cancer.
2. Compared with a group given similar treatment with veronal (which was
non-carcinogenic), the urethane-treated animals showed a* high incidence of
infectious diseases.
3. No pleuropneumonia-like organisms were present in the lungs of the
urethane-treated mice.
4. Treatment with urethane did not cause male sterility.
5. No action on embryonic growth was noted.
To Mr. G. R. Knight, for the photograph, the author expresses his appre-
ciation.
All expenses in connection with this work were borne by the British Empire
Cancer Campaign.
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PREVIOUS work has shown that the elimination of benzpyrene from the
animal body is by way of a series of chemical changes (Weigert and Mottram,
1946). The available evidence suggests that the whole course of the cha.nges
from the benzpyrene to the excretion products-in the case of mice, 8-OH benz-
pyrene-does not take place at one point in the body.
With this as starting-point an attempt has been made to trace the course of
the metabolism at one site. The site chosen for consideration was the skin-
as this is one at which tumour formation occurs at the point of application of
the carcinogen.F. WEIGERT, G. CALCUTT AND A. K. POWELL
MATERIALS AND METHODS.
The animals used throughout these experiments were Strong A mice aged
8-10 weeks. In every case the experimental work was confined to consideration
of an area of '4 square cm. on the flank. The 3:4 benzpyrene was applied as
a solution in acetone through a stencil, as described by Calcutt and Powell (1947).
Prior to application ofthe carcinogen the fur was removed by clipping.
At selected intervals after painting the mice were killed and the treated areas
of skin excised, minced and processed for extraction ofthe metabolites. Quanti-
tative estimations were made of the metabolites and the residual unchanged
benzpyrene. The methods used for the separations and the estimations were
those proposed by Weigert (1947).
It has been shown by Calcutt and Powell (1947) that mice which have been
painted, very rapidly lick the reagent concerned off the skin. So for comparison
a number of arimals were painted and fixed to a board with adhesive tape.
tUnder these conditions they could be maintained fairly well for periods of up to
five hours. Estimations were carried out at intervals in the same manner as
before.
Additional to these in vivo experiments, several series were also carried out
using the in vitro technique, previously described by Weigert, Calcutt and Powell
(1946). By this method measured areas of skin were removed from freshly
killed mice, painted with benzpyrene and floated underside downwards on
Ringer-Locke solution in Petri dishes. These were incubated at 37°C., specimens
being taken at intervals for estimation.
RESULTS.
The general course of the metabolism was followed qualitatively over periods
of up' to 24 hours. Separation of the acetone extracts of the skins was carried
out by both chromatographic and partition methods. Apart from unchanged
benzpyrene the only other compound found to be present was the one labelled
by Weigert and Mottram (1946) as BPX2. This was identified from its fluores-
cence spectrum. No traces of the further metabolic products BPF1 or BPF2
could be found.
Quantitative estimates were undertaken of the rate of formation of the
BPX2. Results for the in vivo paintings of free and fixed animals are shown in
Fig. I and 2. In the case ofthe in vitro technique, a series of results was obtained
using varying concentrations of the 3:4 benzpyrene. These results are given in
Fig. 3-8. Examinations ofthe.Ringer-Locke solutions used in these experiments
failed to show anything in the way of diffused metabolites.
DISCUSSION.
Consideration of the data shown above indicates three important findings.
These are:
The only metabolite found is BPX2.
There is an initial time lag in the production ofthe metabolite.
There is a fairly rapid build-up in the amount of metabolite after the
initial delay period, followed by a slow falling off in the amount present.
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FIG. 1.-Free animals. Each painted with 0*3 mg. benzpyrene in 0.1 c.c. of acetone.
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FIG. 2.-Fixed animals. Each painted with 0-3 mg. benzpyrene in 0.1 c.c. of acetone.
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FIG. 3.-Detached skins.
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Each painted with 0-3 mg. benzpyrene in 0.1 c.c. ofacetone.
x
x
x I x x
4i _x %1~~ I I
x
2 4 6 8 10 12 14 16 18 20 22 24
Time in hours
FIG. 4.-Detached skins. Each painted with 0.1 mg. benzpyrene in 0.1 c.c. of acetone.
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FIG. 5.-Detached skins.
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FIG. 6.-Detached skins.
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Each painted with 0.01 mg. benzpyrene in 0.1 c.c. of acetone.
FIG. 7.-Detached skini
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FIG. 8.-Detached skins. Each painted with 0-002 mg. benzpyrene in 0*1 c.c. ofacetone.
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The fact that BPX2 was the only metabolite found suggests that the further
breakdown products, BPF1 and BPF2, are not formed at the site of application
of the benzpyrene. This, however, is not positively proved, as the experimnents
may not have been continued sufficiently long for the formation to occur. Since,
however, this change occurs rapidly in other parts of the body (Weigert and
Mottram, 1946), it would seem unlikely that there would be any great delay ifthe
process occurred in the skin. Under these circumstances it appears that the
benzpyrene is converted to the water-soluble BPX2 in the skin, but that further
conversion to the final excretion products takes place elsewhere in the body.
If this is so it follows-assuming a causal relationship between metabolism and
carcinogenesis-that the carcinogenic action of the benzpyrene in the skin is
exercised by the benzpyrene itself, by the BPX2 or as a result of the formation
of the BPX2 from the benzpyrene. The compounds BPFI and BPF2 must then
be considered solely as excretion products, and as having no connectionwhatever
with the actual process of carcinogenesis.
Estimations of metabolites after intravenous injections of benzpvrene into
mice showed a preponderance of BPX1 (Weigert and Mottram, 1946). On the
other hand. when the benzpyrene was absorbed slowly as after intraperitoneal
injection, BPX. formedthe bulk ofthe first metabolic products. This, considered
together with the fijidings in respect of skin, suggests that BPXI is formed when
relativelylarge amounts of the benzpyrene are rapidlv brought into contact with
tissues, but that BPX2 is formed when the benzpyrene is slowly introduced.
The production of one or the other is thus a function of the physical conditions
operative at the time of the introduction of the parent hydrocarbon into the
tissues.
The initial time lag before any production of metabolites can be traced is
probably ofpurely mechanical origin, in that time is necessary for the benzpyrene
to pass through the skin to the site at which metabolic conversion takes place.
However, the possibility of some-as yet undiscovered-preliminary reaction
occurring cannot be excluded, though there is no evidence for such an occurrence.
Pending further experimental work the exact cause and significance of this time
lag phenomenon must remain as unanswered questions.
Once the production of the metabolite has commenced, there is a fairly rapid
build-up to a peak value and then a slow decline. Since variation in the amount
of benzpyrene applied has little effect on this general pattern of behaviour, it
appears that the decline is not a function of the amount of residual benzpyrene
present in the unchanged state. The limitation then must be imposed bv some
other factor. The most likely appears to be the using up ofthe available cellular
substrate involved in the formation of the BPX2. This view is, however, still
open to doubt.
The fact that no metabolic products other than BPX2 were found does not
signify that the decline in the amount of the BPX2 is not due to its conversion
into other compounds. The technique used may not have been suitable or
sufficiently delicate to deternmine this point. In any event it can be said that the
loss of the BPX2 from the skin is a relatively slow process as compared to its
formation.
Till the relationship between the metabolism and carcinogenicity of benz-
pyrene is determined, no assessment of the significance of the points discussed
above can be of anything more than academic interest.
409410 H. WEIL-MALHERBE
SUMMARY.
1. Experiments are described in which the determination of the course of
metabolism of 3:4 benzpyrene in mouse skin has been followed both quanti-
tatively and qualitatively over periods of up to 24 hours.
2. The only metabolic product discovered was BPX2.
3. There is an initial time lag of approximately 1 hour before any metabolite
can be found.
4. Once metabolism commences there is a fairly rapid build-up of the meta-
bolite.
5. This build-up reaches a peak value, and then there is a slow decline in the
amount present.
6. The meaning and significance of these findings is discussed.
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ALTHOUGH the fact is now well established that the incidence and latent
period of tumours induc6d by 3:4-benzpyrene depend to some extent on the
solvent employed, a proper understanding ofthis " solvent effect " is still lacking.
This is partly due to the complex nature of the natural oils and fats most fre-
quently used in studies on solvent effects. Their action is the resultant of a
multiplicity of component effects which may be either synergistic or antagonistic.
Progress is more likely to come from a study ofsimple synthetic or near-synthetic
solvent systems which are more amenable to interpretation in terms of bio-
chemical reactions or properties.
The idea that the pro- or anticarcinogenic effects of solvents might be
correlated with differences in the elimination rate of benzpyrene was first formu-
lated by Peacock and Beck (1938) who, on the basis of qualitative visual inspec-
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